13-24434460-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006437.4(PARP4):āc.4681A>Gā(p.Ile1561Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,610,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006437.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARP4 | NM_006437.4 | c.4681A>G | p.Ile1561Val | missense_variant | 31/34 | ENST00000381989.4 | NP_006428.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARP4 | ENST00000381989.4 | c.4681A>G | p.Ile1561Val | missense_variant | 31/34 | 1 | NM_006437.4 | ENSP00000371419 | P1 | |
TPTE2P6 | ENST00000445572.5 | n.233+25156T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152242Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248842Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134354
GnomAD4 exome AF: 0.0000206 AC: 30AN: 1458156Hom.: 0 Cov.: 34 AF XY: 0.0000179 AC XY: 13AN XY: 725168
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152242Hom.: 0 Cov.: 35 AF XY: 0.0000538 AC XY: 4AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.4681A>G (p.I1561V) alteration is located in exon 31 (coding exon 30) of the PARP4 gene. This alteration results from a A to G substitution at nucleotide position 4681, causing the isoleucine (I) at amino acid position 1561 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at